Fiche centre
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou — China
Essais liés9clinical trials
VilleGuangzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07575672
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| single infusion, 1.0 × 10^6 cells/kg | Accident vasculaire cérébral | Phase 1/2 | NCT07896941 | Safety and Efficacy of CG-BM1 in Ischemic Stroke | RECRUITING |
| Difelikefalin | Maladie rénale chronique | Phase 2 | NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | RECRUITING |
| BMS-986504 | Cancer | Phase 2/3 | NCT07063745 | MountainTAP-29 — A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion | RECRUITING |
| Nivolumab | Cancer | Phase 3 | NCT06561386 | RELATIVITY1093 — A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% | RECRUITING |
| Dorzagliatin | Maladie rénale chronique | Non applicable | NCT07786571 | Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency | WITHDRAWN |
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| Cizutamig | Lupus | Phase 1 | NCT07215663 | Clinical Study of Cizutamig in Systemic Lupus Erythematosus | RECRUITING |
| Adagrasib | Cancer | Phase 3 | NCT06875310 | A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) | RECRUITING |
| Telitacicept | Myasthénie | Phase 3 | NCT06456580 | A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) | ACTIVE_NOT_RECRUITING |